EUROPEAN COMMISSION ENVIRONMENT DIRECTORATE

EUROPEAN COMMISSION
ENVIRONMENT DIRECTORATE-GENERAL
Green Economy
Chemicals
ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL
Resources Based, Manufacturing and Consumer Goods Industries
REACH
Chemicals Industry
Brussels, 12 February 2014
Follow-up to the
13th Meeting of Competent Authorities for REACH and CLP (CARACAL)
26 – 27 – 28 November 2013
Centre A. Borschette, Brussels, Belgium
Concerns:
List of opinions adopted by RAC-24, 25, 26 and 27 proposing new
or revised classification in Annex VI, CLP for their potential
inclusion in the 7th Adaptation to Technical Progress (ATP)
Action Requested:
Member States are requested to send their comments on the list of
substances for their potential inclusion in the 7th ATP to CLP by
28th February 2014 by email to [email protected] and
[email protected]
Annex
Table 1. Adopted by RAC-24, 25, 26 and 27 proposed new or revised classification in Annex VI, CLP
Table 1.1 revised entries in Table 3.1 Annex VI, CLP
Index
No
00700400-1
01500300-2
05000800-3
International
Chemical
Identification
nitric acid ... %
calcium phosphide;
tricalcium
diphosphide
tributyltin
compounds, with the
exception of those
specified elsewhere
in this annex
EC No
CAS No
Classification
Hazard Class
and Category
Code(s)
231-714-2
215-142-0
-
Hazard
statement
Code(s)
Ox. Liq. 2
Acute Tox. 1
Skin Corr. 1A
H272
H330
H314
Water-react. 1
Acute Tox. 2
Acute Tox. 3
Acute Tox. 1
Eye Dam. 1
Aquatic Acute 1
Repr. 1B
Acute Tox. 3
Acute Tox. 4*
STOT RE 1
Skin Irrit. 2
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic
1
H260
H300
H311
H330
H318
H400
H360FD
H301
H311
H372**
H315
H319
H400
H410
Labelling
Pictogram
, Signal
Word
Code(s)
GHS03
GHS06
GHS05
Dgr
Hazard
statement
Code(s)
H272
H314
H330
Suppl.
Hazard
statement
Code(s)
EUH071
7697-372
1305-993
-
GHS02
GHS06
GHS05
GHS09
Dgr
GHS08
GHS06
GHS09
Dgr
H260
H300
H311
H330
H318
H400
H360FD
H301
H311
H372**
H315
H319
H410
Specific Conc.
Limits, Mfactors
Note
s
Skin Corr. 1A;
H314: C ≥ 20 %
Skin Corr. 1B;
H314: 5 % ≤ C
< 20 %
Ox. Liq. 2;
H272: C ≥ 99 %
Ox. Liq. 3;
H272: 99 % > C
≥ 65 %
B
EUH029
EUH032
M=100
*
STOT RE 1;
H372: C ≥ 1 %
STOT RE 2;
H373: 0,25 % ≤
C<1%
Skin Irrit. 2; C ≥
1%
Eye Irrit. 2; C ≥
A1
Index
No
International
Chemical
Identification
EC No
CAS No
Classification
Hazard Class
and Category
Code(s)
Hazard
statement
Code(s)
Labelling
Pictogram
, Signal
Word
Code(s)
Hazard
statement
Code(s)
Suppl.
Hazard
statement
Code(s)
Specific Conc.
Limits, Mfactors
1%
M=10
60310200-9
60319700-7
60605400-7
60719700-8
1,2-epoxybutane
tebuconazole (ISO);
1-(4-chlorophenyl)4,4-dimethyl-3(1,2,4-triazol-1ylmethyl)pentan-3ol
isoxaflutole (ISO);
(5-Cyclopropyl-1,2oxazol-4-yl)[2(methylsulfonyl)-4(trifluoromethyl)phe
nyl]methanone
nonanoic acid
203-438-2
403-640-2
-
203-931-2
106-88-7
10753496-3
14111229-0
112-05-0
Flam. Liq. 2
Carc. 2
Acute Tox. 4*
Acute Tox. 4*
Acute Tox. 4*
STOT SE 3
Skin Irrit. 2
Eye Irrit. 2
Aquatic chronic 3
H225
H351
H302
H312
H332
H335
H315
H319
H412
GHS02
GHS08
GHS07
Dgr
H225
H351
H302
H312
H332
H335
H315
H319
H412
Repr. 2
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic
1
H361d***
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H361d***
H302
H410
Repr. 2
Aquatic Acute 1
Aquatic Chronic
1
H361d***
H400
H410
GHS08
GHS09
Wng
H361d***
H410
Skin Irrit. 2
Eye Irrit. 2
Aquatic Chronic
3
H315
H319
H412
GHS07
Wng
H315
H319
H412
3
M=1
M=10
M=10
M=100
Note
s
Index
No
61304200-5
International
Chemical
Identification
imazalil (ISO); 1-[2(allyloxy)-2-(2,4dichlorophenyl)ethyl
]-1H-imidazole
61305700-7
dodemorph (ISO);
4-cyclododecyl-2,6dimethylmorpholine
61313300-X
etridiazole (ISO); 5ethoxy-3trichloromethyl1,2,4-thiadiazole
61314900-7
pyridaben (ISO);
2-tert-butyl-5-(4tertbutylbenzylthio)-4chloropyridazin3(2H)-one
EC No
CAS No
Classification
Hazard Class
and Category
Code(s)
252-615-0
216-474-9
219-991-8
405-700-3
3555444-0
1593-777
2593-159
9648971-3
Hazard
statement
Code(s)
Labelling
Pictogram
, Signal
Word
Code(s)
GHS08
GHS06
GHS05
GHS09
Dgr
Hazard
statement
Code(s)
Carc. 2
Acute Tox. 3
Acute Tox. 4
Eye Dam. 1
Aquatic Chronic
1
Repr. 2
STOT RE 2
Skin Corr. 1C
Skin Sens. 1A
Aquatic Acute 1
Aquatic Chronic
1
H351
H301
H332
H318
H410
H361d
H373
(liver)
H314
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
Carc. 2
Acute Tox. 4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic
1
Acute Tox. 3
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic
1
H351
H302
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H317
H410
H331
H301
H400
H410
GHS06
GHS09
Dgr
H331
H301
H410
4
Suppl.
Hazard
statement
Code(s)
H351
H301
H332
H318
H410
H361d
H373
(liver)
H314
H317
H410
Specific Conc.
Limits, Mfactors
M=10
EUH071
M=1
M=1
M=1
M=1
M=1000
M=1000
Note
s
Table 1.2 new entries in Table 3.1 Annex VI, CLP
Index No International Chemical
Identification
EC No
CAS No
Hazard Class
and Category
Code(s)
019003-003
potassium (E,E)-hexa2,4-dienoate
246376-1
2463461-5
082013-001
lead
231100-4
7439-921
604092-009
606148-008
phenol, dodecyl-,
branched [1];
phenol, 2-dodecyl-,
branched;
phenol, 3-dodecyl-,
branched;
phenol, 4-dodecyl-,
branched;
phenol, (tetrapropenyl)
derivatives [2]
carvone (ISO);
2-methyl-5-(prop-1-en2-yl)cyclohex-2-en-1one; [1]
d-carvone; (5S)-2methyl-5-(prop-1-en-2yl)cyclohex-2-en-1-one;
[2]
l-carvone; (5R)-2methyl-5-(prop-1-en-2yl)cyclohex-2-en-1-one
[3]
Classification
310154-3
[1]
202759-5
[1]
218827-2
[2]
229352-5
[3]
12115858-5 [1]
7449935-7 [2]
Hazard
statement
Code(s)
Labelling
Pictogra
m,
Signal
Word
Code(s)
GSH07
Wng
Hazard
statemen
t Code(s)
Eye Irrit. 2
H319
Repr. 1A
Lact.
H360FD
H362
GHS08
Dgr
H360FD
H362
Repr. 1B
Skin Corr. 1C
Aquatic Acute 1
Aquatic Chronic
1
H360F
H314
H400
H410
GHS05
GHS08
GHS09
Dgr
H360F
H314
H410
Skin Sens. 1
H317
GHS07
Wng
H317
99-49-0
[1]
2244-168 [2]
6485-401 [3]
5
Suppl.
Hazard
statement
Code(s)
Specific
Conc.
Limits, Mfactors
H319
Repr. 1A;
H360D: C ≥
0,03 %
M=10
M=10
Note
s
Index No International Chemical
Identification
606149-003
607707-009
607708-004
tembotrione (ISO); 2-{2chloro-4(methylsulfonyl)-3[(2,2,2trifluoroethoxy)methyl]b
enzoyl}cyclohexane-1,3dione
fenoxaprop-P-ethyl
(ISO); ethyl (2R)-2-{4[(6-chloro-1,3benzoxazol-2yl)oxy]phenoxy}propano
ate
octanoic acid
EC No
CAS No
Classification
Hazard Class
and Category
Code(s)
-
-
204677-5
33510484-2
7128380-2
124-07-2
607709-00X
decanoic acid
206376-4
334-48-5
607710-005
1,2-benzenedicarboxylic
acid, dihexyl ester,
branched and linear
271093-5
6851550-4
607711-000
spirotetramat (ISO);
(5s,8s)-3-(2,5dimethylphenyl)-8methoxy-2-oxo-1azaspiro[4,5]dec-3-en-4-
-
20331325-1
Repr. 2
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic
1
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic
1
Hazard
statement
Code(s)
H361d
H373
(eyes,
kidneys,
liver)
H317
H400
H410
H373
(kidneys)
H317
H400
H410
Labelling
Pictogra
m,
Signal
Word
Code(s)
GHS08
GHS07
GHS09
Wng
Hazard
statemen
t Code(s)
H361d
H373
(eyes,
kidneys,
liver)
H317
H410
GHS08
GHS07
GHS09
Wng
H373
(kidneys)
H317
H410
Skin Corr. 1C
Aquatic Chronic
3
H314
H412
GHS05
Dgr
H314
H412
Skin Irrit. 2
Eye Irrit. 2
Aquatic Chronic
3
H315
H319
H412
GHS07
Wng
H315
H319
H412
Repr. 1B
H360FD
GHS08
Dgr
H360FD
Repr. 2
STOT SE 3
Eye Irrit. 2
Skin Sens. 1A
Aquatic Acute 1
H361fd
H335
H319
H317
H400
GHS08
GHS07
GHS09
Wng
H361fd
H335
H319
H317
H410
6
Suppl.
Hazard
statement
Code(s)
Specific
Conc.
Limits, Mfactors
M=100
M=10
M=1
M=1
M=1
Note
s
Index No International Chemical
Identification
EC No
CAS No
Hazard Class
and Category
Code(s)
yl ethyl carbonate
607712-006
607713-001
607714-007
607715-002
dodemorph acetate; 4cyclododecyl-2,6dimethylmorpholin-4-ium
acetate
fenpyroximate (ISO);
tert-butyl 4-[({(E)-[(1,3dimethyl-5-phenoxy-1Hpyrazol-4yl)methylene]amino}oxy
)methyl]benzoate
triflusulfuron-methyl;
methyl 2-({[4(dimethylamino)-6(2,2,2-trifluoroethoxy)1,3,5-triazin-2yl]carbamoyl}sulfamoyl)3-methylbenzoate
bifenazate (ISO);
Isopropyl 2-(4methoxybiphenyl-3yl)hydrazinecarboxylate
Classification
250778-2
-
-
442820-5
3171787-0
13409861-6
12653515-7
14987741-8
Hazard
statement
Code(s)
Labelling
Pictogra
m,
Signal
Word
Code(s)
Hazard
statemen
t Code(s)
Aquatic Chronic
1
H410
Repr. 2
STOT RE 2
Skin Corr. 1C
Skin Sens. 1A
Aquatic Chronic
1
H361d
H373
(liver)
H314
H317
H410
GHS08
GHS05
GHS07
GHS09
Dgr
Acute Tox. 3
Acute Tox. 2
Skin Sens. 1B
Aquatic Acute 1
Aquatic Chronic
1
H301
H330
H317
H400
H410
GHS06
GHS09
Dgr
Carc. 2
Aquatic Acute 1
Aquatic Chronic
1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic
1
H373
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H373
H317
H410
7
Suppl.
Hazard
statement
Code(s)
Specific
Conc.
Limits, Mfactors
M=1
H361d
H373
(liver)
H314
H317
H410
H301
H330
H317
H410
EUH071
M=1
M=100
M=1000
M=100
M=10
M=1
M=1
Note
s
Index No International Chemical
Identification
613319-000
613320-006
616213-002
616214-008
616215-003
imidazole
lenacil (ISO); 3cyclohexy-6,7-dihydro1hcyclopenta[d]pyrimidine2,4(3h,5h)-dione
mandipropamid (ISO); 2(4-chlorophenyl)-N-{2[3-methoxy-4-(prop-2yn-1yloxy)phenyl]ethyl}-2(prop-2-yn-1yloxy)acetamide
metosulam (ISO); N(2,6-dichloro-3methylphenyl)-5,7dimethoxy[1,2,4]triazolo
[1,5-a]pyrimidine-2sulfonamide
dimethenamid-P (ISO);
2-chloro-N-(2,4dimethyl-3-thienyl)-N[(2S)1-methoxypropan-2yl]acetamide
EC No
CAS No
Classification
Hazard Class
and Category
Code(s)
206019-2
218499-0
-
-
-
288-32-4
2164-081
Hazard
statement
Code(s)
Labelling
Pictogra
m,
Signal
Word
Code(s)
GHS08
GHS07
GHS05
Dgr
Hazard
statemen
t Code(s)
Repr. 1B
Acute Tox. 4
Skin Corr. 1C
H360D
H302
H314
Carc. 2
Aquatic Acute 1
Aquatic Chronic
1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
Aquatic Acute 1
Aquatic Chronic
1
H400
H410
GHS09
Wng
H410
Carc. 2
STOT RE 2
H351
H373
(eyes,
kidneys)
H400
H410
GHS08
GHS09
Wng
H351
H373
(eyes,
kidneys)
H410
H302
H317
H400
H410
GHS07
GHS09
Wng
Suppl.
Hazard
statement
Code(s)
Specific
Conc.
Limits, Mfactors
H360D
H302
H314
M=10
M=10
M=1
M=1
37472662-2
13952885-1
16351514-8
Aquatic Acute 1
Aquatic Chronic
1
Acute Tox. 4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic
1
8
H302
H317
H410
M=1000
M=100
M=10
M=10
Note
s
Index No International Chemical
Identification
616216-009
flonicamid (ISO); N(cyanomethyl)-4(trifluoromethyl)pyridine3-carboxamide
616217-004
sulfoxaflor (ISO);
[methyl(oxo){1-[6(trifluoromethyl)-3pyridyl]ethyl}-λ6sulfanylidene]cyanamide
EC No
CAS No
Classification
Hazard Class
and Category
Code(s)
-
-
Hazard
statement
Code(s)
Acute Tox. 4
H302
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic
1
H302
H400
H410
15806267-0
94657800-3
9
Labelling
Pictogra
m,
Signal
Word
Code(s)
GHS07
Wng
GHS07
GHS09
Wng
Hazard
statemen
t Code(s)
Suppl.
Hazard
statement
Code(s)
Specific
Conc.
Limits, Mfactors
H302
H302
H410
M=1
M=1
Note
s
Table 2. Adopted by RAC-24, 25, 26 and 27 proposed new or revised classification in Annex VI, DSD
Table 2.1 revised entries in Table 3.2, Annex VI, DSD
Index No
007-00400-1
015-00300-2
050-00800-3
603-10200-9
International
Chemical
Identification
nitric acid ... %
calcium phosphide;
tricalcium diphosphide
tributyltin compounds,
with the exception of
those specified
elsewhere in this annex
1,2-epoxybutane
EC No
231-7142
215-1420
-
203-4382
CAS No
7697-37-2
1305-99-3
Classification
Labelling
Concentration Limits
Note
s
O; R8
C; R35
T+; R26
O; R8: C ≥ 65 %
C; R35: C ≥ 20 %
C; R34: 5 % ≤ C < 20 %
B
F; R15/29
T+; R26/28
Xn; R21
R32
Xi; R38-41
N; R50
O; T+
R: 8-26-35
S: (1/2-)26-2836/37/39-45-63
F; T+; N
R: 15/29-21-26/2832-38-41-50
S:(1/2)-22-2836/37/39-43-45-6061-63
Repr. Cat. 2; R60-61
T; R25-48/23/25
Xn; R21
Xi; R36/38
N; R50-53
T; N
R: 21-25-36/3848/23/25-50/53-6061
S: 45-53-60-61
T; R25: C ≥ 2,5 %
Xn; R22: 0,25 % ≤ C < 2,5
%
Xn: R21: C ≥ 1 %
T; R48/23/25: C ≥ 1 %
Xn; R48/20/22: 0,25 % ≤
C<1%
Xi; R36/38: C ≥ 1 %
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C <
2,5 %
R52-53: 0,025 % ≤ C <
0,25 %
F; R11
Carc. Cat. 3; R40
Xn; R20/21/22
Xi; R36/37/38
R52-53
F; Xn
R: 11-20/21/2236/37/38-40-52/53
S: (2-)9-16-2936/37-46-61
-
106-88-7
10
N; R50: C ≥ 0,25 %
A1
603-19700-7
606-05400-7
tebuconazole (ISO);
1-(4-chlorophenyl)-4,4dimethyl-3-(1,2,4triazol-1ylmethyl)pentan-3-ol
isoxaflutole (ISO);
5-cyclopropyl-1,2oxazol-4-yl α, α,αtrifluoro-2-mesyl-p-tolyl
ketone
607-19700-8
nonanoic acid
613-04200-5
imazalil (ISO); 1-[2(allyloxy)-2-(2,4dichlorophenyl)ethyl]1H-imidazole
613-05700-7
dodemorph (ISO); 4cyclododecyl-2,6dimethylmorpholine
613-13300-X
etridiazole (ISO); 5ethoxy-3trichloromethyl- 1,2,4thiadiazole
403-6402
107534-963
-
141112-290
203-9312
112-05-0
252-6150
216-4749
219-9918
35554-44-0
1593-77-7
2593-15-9
Repr. Cat. 3; R63
Xn; R22
N; R50-53
Xn; N
R: 22-50/53-63
S: (2-)22-36/37-6061
Repr. Cat. 3; R63
N; R50-53
Xn; N
R: 50/53-63
S: (2-)36/37-60-61
Xi; R36/38
N; R51-53
Xi; N
R: 36/38-51/53
S: (2-)46-61
Carc. Cat. 3; R40
Xn; R20/22
Xi; R41
N; R51-53
Repr. Cat. 3; R63
C; R34
R43
N; R50-53
Xn; N
R: 20/22-40-4151/53
S: (2-)26-36/37/3946-61
C; N
R: 34-43-50/53-63
S: (1/2-)26-2836/37/39-45-60-61
Carc. Cat. 3; R40
Xn; R22
R43
N; R50-53
Xn; N
R: 22-40-43-50/53
S: (2-)36/37-46-6061
11
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C <25
%
R52-53: 0,25 % ≤ C < 2,5
%
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C <
2,5 %
R52-53: 0,025 % ≤ C <
0,25 %
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C <
10 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C <
25 %
R52-53: 0,25 % ≤ C < 2,5
%
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C <
25 %
R52-53: 0,25 % ≤ C < 2,5
%
613-14900-7
pyridaben (ISO);
2-tert-butyl-5-(4-tertbutylbenzylthio)-4chloropyridazin-3(2H)one
405-7003
T; R23/25
N; R50-53
96489-71-3
T; N
R: 23/25-50/53
S: (1/2-)36/37-4560-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C
< 0,025 %
R52-53: 0,00025 % ≤ C <
0,0025 %
Table 2.2 new entries in Table 3.2, Annex VI, DSD
Index No
019-00300-3
International Chemical
Identification
potassium (E,E)-hexa2,4-dienoate
082-01300-1
lead
604-09200-9
phenol, dodecyl-,
branched [1];
phenol, 2-dodecyl-,
branched;
phenol, 3-dodecyl-,
branched;
phenol, 4-dodecyl-,
branched;
phenol, (tetrapropenyl)
derivatives [2]
EC No
CAS No
246376-1
2463461-5
231100-4
7439-921
310154-3
[1]
- [2]
12115858-5 [1]
7449935-7 [2]
Classification
Labelling
Concentration Limits
Xi; R36
Xi
R: 36
S: (2-)46
Repr. Cat. 1; R60-61
R64
T
R: 60-61-64
S: 45-53
Repr. Cat. 1; R61: C ≥
0,03 %
Repr. Cat. 2; R60
C; R34
N; R50-53
T; N
R: 34-50/53-60
S: 45-53-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C
< 2,5 %
R52-53: 0,025 % ≤ C <
0,25 %
12
Notes
Index No
International Chemical
Identification
606-14800-8
carvone (ISO);
2-methyl-5-(prop-1-en2-yl)cyclohex-2-en-1one; [1]
d-carvone; (5S)-2methyl-5-(prop-1-en-2yl)cyclohex-2-en-1-one;
[2]
l-carvone; (5R)-2methyl-5-(prop-1-en-2yl)cyclohex-2-en-1-one
[3]
606-14900-3
607-70700-9
607-70800-4
tembotrione (ISO); 2-{2chloro-4(methylsulfonyl)-3[(2,2,2trifluoroethoxy)methyl]b
enzoyl}cyclohexane-1,3dione
fenoxaprop-P-ethyl
(ISO); ethyl (2R)-2-{4[(6-chloro-1,3benzoxazol-2yl)oxy]phenoxy}propano
ate
EC No
202759-5
[1]
218827-2
[2]
CAS No
99-49-0
[1]
Classification
Labelling
Concentration Limits
R43
Xi
R: 43
S: (2-)24-37
Repr. Cat. 3; R63
Xn; R48/22
R43
N; R50-53
Xn; N
R: 43-48/22-50/53-63
S: (2-)36/37-46-6061
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C
< 0,25 %
R52-53: 0,0025 % ≤ C <
0,025 %
Xn; R48/22
R43
N; R50-53
Xn; N
R: 43-48/22-50/53
S: (2-)24-37-46-6061
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C <
25 %
R52-53: 0,25 % ≤ C <
2,5 %
C; R34
N; R51-53
C; N
R: 34-51/53
S: (1/2-)26-36/37/3945-61
Xi; R36/38
N; R51-53
Xi; N
R: 36/38-51/53
S: (2-)46-61
Repr. Cat. 2; R60-61
T
R: 60-61
S: 53-45
2244-168 [2]
6485-401 [3]
229352-5
[3]
33510484-2
-
octanoic acid
204677-5
607-70900-X
decanoic acid
206376-4
607-71000-5
1,2-Benzenedicarboxylic
acid, dihexyl ester,
branched and linear
271093-5
7128380-2
124-07-2
334-48-5
6851550-4
13
Notes
Index No
International Chemical
Identification
607-71100-0
spirotetramat (ISO);
(5s,8s)-3-(2,5dimethylphenyl)-8methoxy-2-oxo-1azaspiro[4,5]dec-3-en-4yl ethyl carbonate
607-71200-6
dodemorph acetate; 4cyclododecyl-2,6dimethylmorpholin-4-ium
acetate
607-71300-1
607-71400-7
607-71500-2
613-31900-0
fenpyroximate (ISO);
tert-butyl 4-[({(E)-[(1,3dimethyl-5-phenoxy-1Hpyrazol-4yl)methylene]amino}oxy
)methyl]benzoate
triflusulfuron-methyl;
methyl 2-({[4(dimethylamino)-6(2,2,2-trifluoroethoxy)1,3,5-triazin-2yl]carbamoyl}sulfamoyl)3-methylbenzoate
EC No
CAS No
-
20331325-1
250778-2
3171787-0
-
-
bifenazate (ISO);
Isopropyl 2-(4methoxybiphenyl-3yl)hydrazinecarboxylate
442820-5
imidazole
206019-2
13409861-6
Classification
288-32-4
Concentration Limits
Repr. Cat. 3; R62-63
Xi; R36/37
R43
N; R50-53
Xn; N
R: 36/37-43-50/5362-63
S: (2-)36/37-46-6061
Xi; R43: C ≥ 0,1 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C <
25 %
R52-53: 0,25 % ≤ C <
2,5 %
Repr. Cat. 3; R63
C; R34
R43
N; R51-53
C; N
R: 34-43-51/53-63
S: (1/2-)26-2836/37/39-45-61
C; R34: C ≥ 10 %
Xi: R36/37/38: 5 % ≤ C
< 10 %
T+; R26
Xn; R22
R43
N; R50-53
T+; N
R: 22-26-43-50/53
S: (1/2-)28-36/37-4560-61-63
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C
< 0,25 %
R52-53: 0,0025 % ≤ C <
0,025 %
Carc. Cat. 3; R40
N; R50-53
Xn; N
R: 40-50/53
S: (2-)36/37-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C
< 0,25 %
R52-53: 0,0025 % ≤ C <
0,025 %
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C <
25 %
R52-53: 0,25 % ≤ C <
2,5 %
Repr. Cat 2; R61
Xn; R22
C; R34
T; C
R: 22-34-61
S: 53-45
12653515-7
14987741-8
Labelling
14
Notes
Index No
613-32000-6
616-21300-2
616-21400-8
616-21500-3
International Chemical
Identification
lenacil (ISO); 3cyclohexy-6,7-dihydro1hcyclopenta[d]pyrimidine2,4(3h,5h)-dione
mandipropamid (ISO); 2(4-chlorophenyl)-N-{2[3-methoxy-4-(prop-2yn-1yloxy)phenyl]ethyl}-2(prop-2-yn-1yloxy)acetamide
metosulam (ISO); N(2,6-dichloro-3methylphenyl)-5,7dimethoxy[1,2,4]triazolo
[1,5-a]pyrimidine-2sulfonamide
dimethenamid-P (ISO);
2-chloro-N-(2,4dimethyl-3-thienyl)-N[(2S)-
EC No
218499-0
-
-
-
CAS No
2164-081
Classification
Labelling
Carc. Cat. 3; R40
N; R50-53
Xn; N
R: 40-50/53
S: (2-)36/37-60-61
N; R50-53
N
R: 50/53
S: 60-61
Carc. Cat. 3; R40
Xn; R48/22
N; R50-53
Xn; N
R: 40-48/22-50/53
S: (2-)36/37-46-6061
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤
C < 0,025 %
R52/53: 0,00025 % ≤ C
< 0,0025 %
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C
< 2,5 %
R52-53: 0,025 % ≤ C <
0,25 %
37472662-2
13952885-1
16351514-8
1-methoxypropan-2yl]acetamide
616-21600-9
flonicamid (ISO); N(cyanomethyl)-4(trifluoromethyl)pyridine3-carboxamide
616-21700-4
sulfoxaflor (ISO);
[methyl(oxo){1-[6(trifluoromethyl)-3pyridyl]ethyl}-λ6sulfanylidene]cyanamide
-
15806267-0
94657800-3
Concentration Limits
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C
< 2,5 %
R52-53: 0,025 % ≤ C <
0,25 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C
<25 %
R52-53: 0,25 % ≤ C <
2,5 %
Xn
R: 22
S: (2-)46
Xn; R22
Xn; R22
N; R50-53
15
Xn; N
R: 22-50/53
S: (2-)60-61
N; R50-53: C ≥ 25%
N; R51-53: 2,5% ≤ C <
25%
R52-53: 0,25% ≤ C <
2,5%
Notes
16